Navigation Links
Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
Date:9/18/2007

Z-004 in 129 schizophrenic patients with acute agitation. In that trial, the 10 mg dose of AZ-004 met the primary endpoint of the clinical trial, showing a statistically significant (p < 0.05) reduction in agitation compared to placebo. The primary endpoint in the trial was the change in the PANSS (Positive and Negative Symptom Scale) Excited Component (PEC) score at the 2-hour post-dose time point.

PEC Scores (Mean Values)

p-value

Study Arm Baseline 2-hour Post-Dose vs. placebo

10 mg AZ-004 17.3 8.8 0.0001

5 mg AZ-004 17.6 10.8 0.088

Placebo 17.7 12.7 -

The 10 mg dose of AZ-004 also exhibited a rapid onset of effect. At 20 minutes post-dose, the 10 mg dose showed statistically significant improvement in the PEC score, compared to placebo. The effectiveness of the 10 mg dose was sustained throughout the 24-hour study period, compared to placebo.

Using the Behavioral Activity Rating Scale (BARS), the 10 mg dose of AZ-004 showed statistically significant improvement, compared to placebo, beginning at 30 minutes. This response was sustained throughout the 24-hour study period, compared to placebo.

Clinical Global Impression-Severity (CGI-S) scale ratings to measure agitation were completed at baseline, immediately prior to AZ-004 administration. At the 2-hour post-dose time point, a Clinical Global Impression-Improvement (CGI-I) evaluation was completed for each patient. Both the 10 mg and the 5 mg doses of AZ-004 showed statistically significant improvements in the CGI-I scale, compared to placebo.

Side effects were recorded throughout the clinical trial period. The administration of AZ-004 was generally safe and well tolerated. The most common side effects reported were taste, sedation and dizzines
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. A smoke free place to be initiated
2. Stem Cell Treatment For Children With Brain Injury To Be Initiated
3. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
4. Massive Production Of Bird Flu Vaccine To Be Initiated In China
5. Exclusive Team initiated To Check Bird Flu Pandemic: Jakarta
6. Chugai Pharmaceutical To Initiate Domestic Production Of Bird Flu Vaccine
7. Bird Flu: Orissa Initiates Protective Measures
8. Biota Initiates Drug Testing War against Common Cold
9. HIV/AIDS Vaccine Trial To Be Initiated Soon
10. Large Scale Multiple Sclerosis Vaccine Trial to Be Initiated By PharmaFrontiers
11. Russia Initiates Mass Vaccination Of Poultry To Restrict Bird Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... CALIF. (PRWEB) September 16, 2014 ... and customer service solutions, announced today that the ... in Learning Award for the creation of a ... contractor agents. Brandon Hall Group honors companies that ... processes, systems and tools that have helped companies ...
(Date:9/16/2014)... 2014 As part of Child Passenger ... Saturday, Sept. 20, Amica Insurance is reminding ... and secure while in the car. , According to ... Safety Administration (NHTSA), 20 percent of drivers of ... manual when installing child restraints. However, 90 percent of ...
(Date:9/16/2014)... 2014 RxAnte, the leading platform ... targeted clinical programs, today announced key changes to ... Company’s drive to improve medication effectiveness through the ... On September 2, 2014, Brock Hardaway, chief executive ... that RxAnte founder and President Josh Benner has ...
(Date:9/16/2014)... Hudson County, NJ (PRWEB) September 16, 2014 ... that a leading Bariatric Surgeon, Leigh Montes, MD, ... of Bariatric Surgery at Christ Hospital. Our system ... Bariatric Center, a medical and surgical weight loss ... through the most advanced bariatric surgery procedures, including ...
(Date:9/16/2014)... 2014 Regulatory intelligence (RI), the ... has become a crucial skill for regulatory professionals ... sectors. Regulatory Intelligence 101 , new from ... serves as an essential guide to the basics ... examines available regulatory intelligence tools, both free and ...
Breaking Medicine News(10 mins):Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:Amica Offers Tips During Child Passenger Safety Week 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 3Health News:Top Bariatric Surgeon Joins CarePoint Health 2Health News:Top Bariatric Surgeon Joins CarePoint Health 3Health News:RAPS Publishes Regulatory Intelligence 101 Book 2
... who showed that a single prostate specific antigen (PSA) test ... prostate cancer up to 25 years later, (regardless of clinical ... used to predict advanced prostate cancer. , The findings, ... help physicians identify which men would benefit from intensive screening. ...
... for,International Development (USAID) announced a $70 million, five-year,program ... countries.,Fistula Care aims to increase access to emergency ... their capacity to provide surgical,fistula repair. The program ... increase understanding about obstetric fistula and steps to,prevent ...
... His Royal Highness, The Duke of York,was the ... to mark the United States,launch of UK-based specialty ... US product, Sancuso, is currently under,consideration for licensing ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080214/NYTH111 ), Prince Andrew ...
... the human cell, certain proteins are the production managers, ... the National Institute of General Medical Sciences (NIGMS), part ... clearer understanding of how a key protein controls gene ... disease. The work could provide new avenues to design ...
... MONTREAL, Feb. 14 /PRNewswire-FirstCall/ - CryoCath(R) Technologies,Inc., the ... announced financial results for the first quarter, ended,December 31, ... Highlights: - EP Revenue for Q1 2008 ... over Q1 2007. All regions around ...
... SANTA MONICA, Calif., Feb. 14 /PRNewswire-USNewswire/ - The ... letter to the state,s HMO,regulator calling for swift ... as "double agents," combing medical records for any,excuse ... Governor Arnold Schwarzenegger told the Los Angeles Times ...
Cached Medicine News:Health News:Early warning: PSA testing can predict advanced prostate cancer 2Health News:USAID Awards $70 Million for the Prevention and Treatment of Obstetric Fistula 2Health News:His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States 2Health News:His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States 3Health News:Enzyme structure reveals new drug targets for cancer and other diseases 2Health News:CryoCath Announces Fiscal 2008 First Quarter Results 2Health News:CryoCath Announces Fiscal 2008 First Quarter Results 3Health News:CryoCath Announces Fiscal 2008 First Quarter Results 4Health News:CryoCath Announces Fiscal 2008 First Quarter Results 5Health News:CryoCath Announces Fiscal 2008 First Quarter Results 6Health News:CryoCath Announces Fiscal 2008 First Quarter Results 7Health News:CryoCath Announces Fiscal 2008 First Quarter Results 8Health News:CryoCath Announces Fiscal 2008 First Quarter Results 9Health News:CryoCath Announces Fiscal 2008 First Quarter Results 10Health News:CryoCath Announces Fiscal 2008 First Quarter Results 11Health News:FTCR: Gov. Schwarzenegger Must Follow Through on Call to Ban Blue Cross From Using Doctors as Double-Agents to Dump Sick Patients 2
(Date:9/16/2014)...  Denovo Biopharma, LLC, today announced that it ... Eli Lilly and Company (NYSE:  LLY). Denovo gains ... globally, including transfer of all intellectual property and ... Lilly developed enzastaurin in a variety of indications, ... trials for diffuse large B-cell lymphoma (DLBCL). In ...
(Date:9/16/2014)... -- EHE International, the recognized leader in preventive medicine and ... that David Abrams M.D . in Tarzana, ... center. Through David Abrams M.D ., EHE members in ... access to EHE,s preventive care programs to help proactively maintain ... Dr. Abrams M.D. to its growing private provider network. With ...
(Date:9/16/2014)... , Sept. 16, 2014  Advanced Medical ... stage development company engaged primarily in the ... for diagnostic and therapeutic applications, today announced ... related to its brachytherapy products.  AMIC,s rights ... its license from Battelle, under which AMIC ...
Breaking Medicine Technology:Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine 2EHE International Certifies David Abrams M.D. as Its Newest Partner 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 4
... guide low-income,and minority cancer patients through cancer treatment, ... major obstacles that prevent them,from receiving quality care ... October 28, 2007, at the American Society for ... Angeles. Minority and low-income cancer patients continue ...
... FLUSHING, N.Y., Oct. 30 The following is,being issued by New York Hospital Queens:, ... aureus(MRSA) is scheduled for ... James Rahal, M.D., and a team of infectious disease ... will address the ...
Cached Medicine Technology:Patient Navigators Help Minority, Low-Income Cancer Patients Get Life-Saving Treatments 2Hospital to Hold MRSA Briefing for Media and Community Leaders 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: